Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single- and multi-voxel proton magnetic resonance spectroscopy study

Abstract

Background: Subjective cognitive decline plus could be an extremely early phase of Alzheimer's disease; however, changes of N-acetylaspartate, myoinositol, and N-acetylaspartate/myoinositol is still unknown at this stage. This study aimed to explore brain neurometabolic alterations in patients with subjective cognitive decline plus using quantitative single-voxel and multi-voxel 1H-magnetic resonance spectroscopy.Methods: A total of 91 participants were enrolled and underwent a GE 3.0-T magnetic resonance imaging, including 33 elderly controls, 27 patients with subjective cognitive decline plus, and 31 patients with amnestic mild cognitive impairment (MCI). Single-voxel and multi-voxel 1H-magnetic resonance spectroscopy were used to investigate the differences in neurometabolite levels among the three groups.Results: Compared with elderly controls, patients with subjective cognitive decline plus showed significant decline in N-acetylaspartate and N-acetylaspartate/ myoinositol values in multiple regions, and amnestic MCI participants demonstrated more significant decreased N-acetylaspartate and N-acetylaspartate/ myoinositol levels in multiple regions. The combined concentrations of N-acetylaspartate with myoinositol showed an excellent discrimination between those with subjective cognitive decline plus and elderly controls as compared to that obtained using N-acetylaspartate/myoinositol ratios with the area under the receiver operating characteristic curve of 0.895 and 0.860, respectively. Likewise, the combined area under the curve for differentiating patients with subjective cognitive decline plus from amnestic MCI was obtained using the combined levels of N-acetylaspartate with myoinositol was 0.892. This was also higher than the combined area under the curve of 0.836 obtained using N-acetylaspartate/myoinositol ratios. Moreover, N-acetylaspartate levels in the left hippocampus and left posterior cingulate cortex (PCC) was positively related to the Auditory Verbal Learning Test delayed recall scores in patients with subjective cognitive decline plus, whereas only the N-acetylaspartate/myoinositol ratio was positively related to this scale scores in the left hippocampus.Conclusions: Quantitative single-voxel and multi-voxel 1H-magnetic resonance spectroscopy can provide valuable information to detect alterative brain neurometabolites characteristics in patients with subjective

Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study

“…In our study, we demonstrated that an increasing annualized MDASI delayed score (worsening) was associated with a decline in annualized NAA in the medial frontal region, which is consistent with earlier research. [ 16 , 25 , 26 ] Contrary to earlier assumptions, our study and another study demonstrated that Cr was not stable in patients who received chemotherapy. [ 16 ] MRS data are commonly presented either as concentration ratio relative to creatine (assuming that creatine is not affected by the pathology) or as a concentration utilizing the water signal obtained from the corresponding volume of interest as a reference.…”

MRS in neurodegenerative dementias, prodromal syndromes and at‐risk states: A systematic review of the literature

“…83 Relatively few papers in this review calculated Cr concentration and most did not report significant results. Where differences were found, Cr was found to be lower in patient groups (AD, MCI and DLB) across a range of regions 51,54,77,94 but higher in older controls in 'at-risk' cohorts. 83,86 These results underscore the problem of using Cr as a reference region, especially within dementia research, as the relationship of Cr with disease and age is unclear.…”

“…47,51 Ten studies considered Cr (or tCr) as a metabolite of interest: seven reported no significant results 26,29,32,42,46,50,53 ; one found lower ACC and PCC Cr in AD and MCI groups compared with controls but no significant difference between AD and MCI groups 51 ; another found lower left dorsal thalamic tCr in MCI compared with controls. 54 A functional MRS study found that changes in PCC tCr between three stimulation conditions differentiated between AD, MCI and controls with relatively high sensitivity and specificity (highest for AD versus controls, sensitivity 87.5, specificity 63.89). 94…”

Quantitative morphometric changes in vascular mild cognitive impairment patients: early diagnosis of dementia

“…2021 ). However, few studies have performed direct pathological investigations to analyze the histology underlying brain volume changes in VMCI ( Yang, Wan, et al. 2021 ).…”